• Users Online: 122
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others


Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan

Chiang Tsung-Ta, Tang Hung-Jen, Chiu Cheng-Hsun, Chen Te-Li, Ho Mao-Wang, Lee Chen-Hsiang, Sheng Wang-Huei, Yang Ya-Sung

Year : 2016| Volume: 36| Issue : 6 | Page no: 229-233

   This article has been cited by
1 Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?
Yee-Huang Ku,Wen-Liang Yu
Infection, Genetics and Evolution. 2021; : 104707
[Pubmed]  [Google Scholar] [DOI]
2 Clinical Efficacy and Safety of Cefoperazone–Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis
Shao-Huan Lan,Chien-Ming Chao,Shen-Peng Chang,Li-Chin Lu,Chih-Cheng Lai
Surgical Infections. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
Ming-Jen Sheu,Chi-Chung Chen,Ying-Chen Lu,Bo-An Su,Chun-Cheng Zhang,Shu-Shen Wang,Yin-Ching Chuang,Hung-Jen Tang,Chih-Cheng Lai
Antibiotics. 2020; 9(2): 77
[Pubmed]  [Google Scholar] [DOI]
4 Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia
Jien-Wei Liu,Yen-Hsu Chen,Wen-Sen Lee,Jung-Chung Lin,Ching-Tai Huang,Hsi-Hsun Lin,Yung-Ching Liu,Yin-Ching Chuang,Hung-Jen Tang,Yao-Shen Chen,Wen-Chien Ko,Min-Chi Lu,Fu-Der Wang
Antimicrobial Agents and Chemotherapy. 2019; 63(8)
[Pubmed]  [Google Scholar] [DOI]
5 The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
Ping-Chin Chang,Chi-Chung Chen,Ying Chen Lu,Chih-Cheng Lai,Hui-Ling Huang,Yin-Ching Chuang,Hung-Jen Tang
Journal of Microbiology, Immunology and Infection. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article